1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. DGK

DGK (二酰甘油激酶)

Diacylglycerol kinase;

DGK (二酰基甘油激酶) 调节 DAG 和磷脂酸 (PA) 之间的平衡。DGK 磷酸化 DAG 以生成 PA。DGK 有 10 种哺乳动物DGK亚型 (α-κ),且具有亚型特异的组织分布,可分为5类。其中,DGKα 和 DGKζ 特异性调节在刺激 T 细胞受体后作为第二信使产生的 DAG 库。而 DGKζ 是 T 细胞中的主要亚型。某些 DGK 亚型的失调会导致 PKC 的 DAG 激活、胰岛素信号减弱和葡萄糖代谢失调。DGK 在许多生理事件中发挥作用,包括细胞增殖和迁移、葡萄糖摄入、免疫和神经元网络构建[1][2][3]

DGK (Diacylglycerol Kinase) modulates the balance between DAG and phosphatidic acid (PA). DGK phorylates DAG to generate PA. DGK has ten mammalian DGK subtypes (α-κ) with subtype-specific tissue distribution, and they can be classified into 5 types. Among them, DGKα and DGKζ specifically regulate the pool of DAG that is generated as a second messenger after stimulation of the T cell receptor. Whereas, DGKζ is the dominant isoform in T cells. Dysregulation of certain DGK isoforms leads to DAG-activation of PKC, attenuation of insulin signaling, and dysregulation of glucose metabolism. DGK plays a role in many physiological events, including cell proliferation and migration, glucose intake, immunity and neuronal network construction[1][2][3].

DGK 相关产品 (23):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-149667
    BMS-332 Inhibitor
    BMS-332 是 DGKα/ζ 脂激酶双抑制剂,IC50 分别为 0.005 μM (DGKα) 和 0.001 μM (DGKζ)。
    BMS-332
  • HY-156573
    DGKα&ζ-IN-1 Inhibitor
    DGKα&ζ-IN-1 (Compound II) 是一种DGK靶点抑制剂。DGKα&ζ-IN-1 能增强 T 细胞功能,与 PD-1 联用具有协同作用,在免疫和肿瘤方面都有治疗效果。
    DGKα&ζ-IN-1
  • HY-156574
    DGKζ-IN-4 Inhibitor
    DGKζ-IN-4 是一种 DGKζ 抑制剂。DGKζ-IN-4 可用作药物组合物的活性成分。DGKζ-IN-4 用于治疗与免疫细胞活化相关的癌症或对抗 PD-1 抗体/抗 PD-11 抗体治疗具有抗性的癌症。
    DGKζ-IN-4